NCT05500586View on ClinicalTrials.gov

The Effects of Glucagon on Hepatic Metabolism

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions

ObesityType2diabetesNAFLD

Interventions

DRUG

Glucagon response study

Please see information in group descriptions

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

All Listed Sponsors

lead

Adrian Vella

OTHER